Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prophylactic Anticoagulation in Adult Patients with Nephrotic Syndrome.

Literature DB >> 31575616

Prophylactic Anticoagulation in Adult Patients with Nephrotic Syndrome.

Judit Gordon-Cappitelli¹, Michael J Choi².

Abstract

Entities: Disease Species

Keywords: adult; blood coagulation; humans; nephrotic syndrome; pain management; prophylactic anticoagulation; thrombolytic therapy; thrombosis

Mesh：

Substances：
Anticoagulants

Year: 2019 PMID： 31575616 PMCID： PMC6946067 DOI： 10.2215/CJN.05250419

Source DB: PubMed Journal: Clin J Am Soc Nephrol ISSN： 1555-9041 Impact factor: 8.237

× No keyword cloud information.

9 in total

1. Venous thromboembolism in patients with membranous nephropathy.

Authors: Sophia Lionaki; Vimal K Derebail; Susan L Hogan; Sean Barbour; Taewoo Lee; Michelle Hladunewich; Allen Greenwald; Yichun Hu; Caroline E Jennette; J Charles Jennette; Ronald J Falk; Daniel C Cattran; Patrick H Nachman; Heather N Reich
Journal: Clin J Am Soc Nephrol Date: 2011-11-10 Impact factor: 8.237

2. Patients with primary membranous nephropathy are at high risk of cardiovascular events.

Authors: Taewoo Lee; Vimal K Derebail; Abhijit V Kshirsagar; Yunro Chung; Jason P Fine; Shannon Mahoney; Caroline J Poulton; Sophia Lionaki; Susan L Hogan; Ronald J Falk; Daniel C Cattran; Michelle Hladunewich; Heather N Reich; Patrick H Nachman
Journal: Kidney Int Date: 2016-02-26 Impact factor: 10.612

3. Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy.

Authors: Taewoo Lee; Andrea K Biddle; Sofia Lionaki; Vimal K Derebail; Sean J Barbour; Sameer Tannous; Michelle A Hladunewich; Yichun Hu; Caroline J Poulton; Shannon L Mahoney; J Charles Jennette; Susan L Hogan; Ronald J Falk; Daniel C Cattran; Heather N Reich; Patrick H Nachman
Journal: Kidney Int Date: 2013-12-11 Impact factor: 10.612

4. Retrospective analysis of a novel regimen for the prevention of venous thromboembolism in nephrotic syndrome.

Authors: Nicholas Medjeral-Thomas; Stela Ziaj; Marie Condon; Jack Galliford; Jeremy Levy; Tom Cairns; Megan Griffith
Journal: Clin J Am Soc Nephrol Date: 2013-12-12 Impact factor: 8.237

5. Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis.

Authors: Sean J Barbour; Allen Greenwald; Ognjenka Djurdjev; Adeera Levin; Michelle A Hladunewich; Patrick H Nachman; Susan L Hogan; Daniel C Cattran; Heather N Reich
Journal: Kidney Int Date: 2011-09-14 Impact factor: 10.612

6. Should aspirin be used for primary prevention of thrombotic events in patients with membranous nephropathy?

Authors: Julia M Hofstra; Jack F M Wetzels
Journal: Kidney Int Date: 2016-05 Impact factor: 10.612

7. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study.

Authors: Bakhtawar K Mahmoodi; Min Ki ten Kate; Femke Waanders; Nic J G M Veeger; Jan-Leendert P Brouwer; Liffert Vogt; Gerjan Navis; Jan van der Meer
Journal: Circulation Date: 2007-12-24 Impact factor: 29.690

Review 8. Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum.

Authors: Richard J Glassock
Journal: J Am Soc Nephrol Date: 2007-06-28 Impact factor: 10.121

9. Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications.

Authors: Sarah Kelddal; Karen Marie Nykjær; Jon Waarst Gregersen; Henrik Birn
Journal: BMC Nephrol Date: 2019-04-25 Impact factor: 2.388

9 in total

5 in total

5. Prophylactic anticoagulants to prevent venous thromboembolism in patients with nephrotic syndrome-A retrospective observational study.

Authors: Frida Welander; Henrik Holmberg; Emöke Dimény; Ulf Jansson; Anders Själander
Journal: PLoS One Date: 2021-07-28 Impact factor: 3.240